Skip to content
← Full study record

NCT01435122 · MORE INFO

Limitations, agreements, and source contact

A Study of Axitinib in Advanced Carcinoid Tumors · Source last updated 2018-10-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
Results are limited by a relatively high rate of participant withdrawal before progression due to toxicity. Post analysis, 2 participants are still on study at UCSF.
point Of Contact
email
jonathan.strosberg@moffitt.org
organization
H. Lee Moffitt Cancer Center and Research Institute
phone
813-745-3636
title
Dr. Jonathan R. Strosberg
Complete source fields
certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
Results are limited by a relatively high rate of participant withdrawal before progression due to toxicity. Post analysis, 2 participants are still on study at UCSF.
point Of Contact
email
jonathan.strosberg@moffitt.org
organization
H. Lee Moffitt Cancer Center and Research Institute
phone
813-745-3636
title
Dr. Jonathan R. Strosberg

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice